Core Insights - The "Golden Award" annual excellence company selection by Gelonghui will reveal a list of notable companies, highlighting those recognized for their contributions to ESG (Environmental, Social, Governance) principles [1][2] Group 1: Award Winners - Ten companies have been awarded the "Annual ESG Pioneer Award (Large Market Capitalization)," including Aier Eye Hospital, Beike, Bosideng, Mengniu Dairy, CATL, Tongcheng Travel, Weichai Power, China Feihe, China State Construction International, and Sinotruk [1] - The award aims to identify companies that balance economic efficiency with social responsibility, recognizing their outstanding contributions to promoting ESG concepts and pursuing high-quality sustainable development [1] Group 2: Evaluation Process - The selection process for the awards involved quantitative data analysis and evaluation by an expert review panel to determine the final results [1] - The "Golden Award" aims to create a reference list of the most valuable listed companies and unicorns in the investment community, covering all listed companies on major exchanges including the Hong Kong Stock Exchange, Shanghai Stock Exchange, Shenzhen Stock Exchange, New York Stock Exchange, and NASDAQ [2]

Core Viewpoint - Feihe has launched the world's first raw material traceability system for infant formula, allowing consumers to trace the production information of key ingredients like whey protein and lactoferrin through a simple scan, enhancing transparency and safety in product selection [1][6]. Group 1: Product Innovation - The introduction of the raw material traceability system is a significant innovation aligned with Feihe's philosophy of providing products better suited for Chinese infants [1][10]. - Feihe's new products, Jicui and Qicui, utilize raw materials produced within 30 days, emphasizing freshness and safety [6][8]. - The traceability system allows consumers to verify the freshness of ingredients, addressing concerns about the quality of infant formula [6][8]. Group 2: Industry Context - A survey by iResearch indicates that 85% of mothers prioritize "freshness" when selecting infant formula, highlighting the importance of ingredient freshness in product quality [3]. - The industry typically relies on imported raw materials, which can lead to safety concerns due to long transportation times and nutrient loss [3][10]. - Feihe's approach of 100% self-sourced key ingredients and the use of advanced extraction techniques significantly enhances the freshness of their products, with some ingredients being 23 to 47 times fresher than traditional sources [3][5][10]. Group 3: Nutritional Advancements - Feihe's proprietary extraction process has resulted in a 98% reduction in certain components while improving protein purity and nutritional quality [3][10]. - The new products feature advanced formulations that closely mimic the nutritional profile of breast milk, with clinical trials showing promising results in immune and brain development indicators [8][10]. - The company has established a robust research foundation, including a national team focused on breast milk research, to support its commitment to high-quality nutrition for infants [10][13].

Core Viewpoint - Feihe has launched the world's first raw material traceability system for infant formula, allowing consumers to trace the production information of key ingredients like whey protein and lactoferrin through a simple scan, enhancing transparency and consumer confidence in product safety and freshness [1][4]. Group 1: Product Innovation - The launch of the traceability system is a significant innovation in Feihe's philosophy of providing products better suited for Chinese babies, emphasizing the importance of fresh and safe ingredients [1][7]. - Feihe's new products, Jicui and Qicui, utilize raw materials produced within 30 days, significantly improving the freshness of ingredients and establishing a new standard for infant formula [4][8]. Group 2: Industry Context - A survey by iResearch indicates that 85% of mothers prioritize "freshness" when selecting infant formula, highlighting the industry's need for improved ingredient sourcing and safety [2]. - The industry currently relies heavily on imported raw materials, which can lead to safety concerns due to long transportation times and nutrient loss [2][11]. Group 3: Technological Advancements - Feihe has achieved 100% self-sourcing of 11 key raw materials, utilizing advanced "fresh extraction technology" to enhance the freshness of its products, with whey protein being 23 times fresher than traditional sources [2][5]. - The company has developed a unique nano-level bio-membrane chromatography process for whey protein, and its casein phosphopeptide has a freshness level 47 times higher than traditional materials, improving absorption by 6.4 times [2][5]. Group 4: Nutritional Science - The new products focus on nutritional synergy and scientific formulation, closely mimicking the nutritional profile of breast milk, with Jicui enhancing immune support and Qicui targeting brain development [6][9]. - Clinical trials have shown that Jicui closely matches breast milk in nine key immune indicators, while Qicui supports brain development at a rate 1.2 times faster than traditional formulas [6][9]. Group 5: Commitment to Safety and Standards - Feihe has maintained a 63-year record of safety with zero accidents, continuously redefining industry standards for freshness and safety [7][11]. - The company has established a fresh milk-to-powder standard system, leading the industry in setting benchmarks for quality and safety in infant nutrition [10][12].

12月21日，"飞鹤杯"全国冬季徒步大会火热开启，这是伊春市首届冰雪森林穿越超级联赛的系列赛事之 一。此次活动，作为赛事合作伙伴，飞鹤旗下功能营养品牌"爱本"的产品，全面助力赛事的顺利进行， 为运动员们加油喝彩。 中国飞鹤副总裁卢光出席了本次活动。"作为一家在黑土地上长大的企业，飞鹤始终与这片沃土共生共 荣，更以'全生命周期营养'为核心，将品牌理念与体育运动结合，积极推动全民健康生态与冰雪运动事 业"，卢光表示，"冰雪运动是活力与拼搏的象征，更是健康中国建设的重要载体。飞鹤希望以实际行 动，为每一位热爱运动的参与者注入健康动能。" ( 中国飞鹤副总裁卢光 ) 精准营养 构建全民健康新生态 冰雪森林穿越超级联赛作为伊春市2025-2026冬季冰雪旅游"百日行动"的重要组成部分，旨在通过多样 化的体验，进一步激发冬季旅游市场活力，促进体育与旅游深度融合，推动地方文旅产业与经济发展。 活动现场，飞鹤"爱本"品牌小分子乳蛋白系列全线产品助力，让大家在感受冰雪魅力的同时，获得专业 健康守护。 (" 飞鹤杯 " 全国冬季徒步大会现场 ) 飞鹤爱本表示："为中老年健康提供精准功能营养方案是飞鹤爱本坚持的长期事业。未来将继续 ...

股票名称 回购数 回购额 年累计回购数量(股) 年累计回购数量/总股本 腾讯控股(00700) 103.80 万 6.36 亿 9567.90 万 1.041% 小米集团-W(01810) 375.00 万 1.52 亿 1.27 亿 0.490% 中远海控(01919) 396.55 万 5366.89 万 1.05 亿 3.635% 快手-W(01024) 75.50 万 4995.09 万 1326.87 万 0.310% 中国飞鹤(06186) 852.90 万 3577.02 万 2.51 亿 2.765% 吉利汽车(00175) 90.70 万 1526.02 万 1801.20 万 0.179% 巨子生物(02367) 40.00 万 1405.36 万 360.00 万 0.336% 明源云(00909) 300.00 万 925.33 万 4957.20 万 2.566% 碧桂园服务 (06098) 100.00 万 625.95 万 5531.10 万 1.656% 百胜中国(09987) 1.59 万 597.96 万 1810.43 万 4.860% 百胜 中国(09987) 6.59 ...

证券时报·数据宝统计显示，12月19日有54家香港上市公司进行了股份回购，合计回购3380.52万股，回 购金额10.12亿港元。 腾讯控股回购数量103.80万股，回购金额6.36亿港元，回购最高价为617.000港元，最低价为607.000港 元，年内累计回购金额762.23亿港元；小米集团-W回购数量375.00万股，回购金额1.52亿港元，回购最 高价为40.560港元，最低价为40.420港元，年内累计回购金额55.40亿港元；中远海控回购数量396.55万 股，回购金额5366.89万港元，回购最高价为13.730港元，最低价为13.470港元，年内累计回购金额66.68 亿港元。 以金额进行统计，12月19日回购金额最多的是腾讯控股，回购金额为6.36亿港元；其次是小米集团- W，回购金额为1.52亿港元；回购金额居前的还有中远海控、快手-W等。回购数量上看，12月19日回购 股数最多的是中国飞鹤，当日回购量为852.90万股；其次是中远海控、小米集团-W等，回购数量分别 为396.55万股、375.00万股。 值得关注的是，本次回购6.36亿港元的腾讯控股，年内则进行多次回购，合计回购金额为7 ...

Core Viewpoint - China Feihe, despite having nearly 6.5 billion in cash, has invested 700 million in bank wealth management products, indicating a strategic approach to managing excess liquidity and seeking better returns [1][3]. Group 1: Investment Activities - Recently, China Feihe's wholly-owned subsidiary, Heilongjiang Feihe Sales, purchased a 700 million wealth management product from Citic Bank, with expected returns between 2.4% and 2.9%, maturing in one year [3]. - This 700 million investment is part of a larger trend, as the company has announced similar purchases 19 times in 2025, totaling over 4 billion [3]. - Currently, there is still 2.2 billion in principal invested in wealth management products at Citic Bank alone [3]. Group 2: Financial Position - As of the first half of the year, China Feihe reported cash and cash equivalents exceeding 6.4 billion, indicating a strong liquidity position [5]. - The company has become a "cash cow" in the industry due to its high-end strategy, generating significant profits [5]. Group 3: Market Challenges - The declining birth rate and intense competition in the infant formula market have led to a slowdown in revenue growth for China Feihe [7]. - As finding new growth opportunities becomes challenging, the large amount of idle funds has made wealth management a preferred option for the company [9]. Group 4: Future Considerations - The company's investment in wealth management may reflect the broader challenges faced by the infant formula industry as it matures and seeks transformation [10]. - There is uncertainty about whether these investments are a temporary measure or indicate a shift in the company's strategic focus [10].

证券时报·数据宝统计，中国飞鹤在港交所公告显示，12月19日以每股4.070港元至4.200港元的价格回购 852.90万股，回购金额达3577.02万港元。该股当日收盘价4.160港元，上涨2.46%，全天成交额1.75亿港 元。 自12月17日以来公司已连续3日进行回购，合计回购1452.00万股，累计回购金额5996.60万港元。 其间 该股累计上涨2.21%。 今年以来该股累计进行40次回购，合计回购2.51亿股，累计回购金额10.64亿港元。（数据宝） 中国飞鹤回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.19 | 852.90 | 4.200 | 4.070 | 3577.02 | | 2025.12.18 | 304.60 | 4.050 | 4.020 | 1232.69 | | 2025.12.17 | 294.50 | 4.040 | 4.020 | 1186.89 | | 2025.12.12 | 565.50 | 4.100 | 4 ...

智通财经APP讯，中国飞鹤(06186)发布公告，于2025年12月19日斥资3577.02万港元回购852.9万股。 （原标题：中国飞鹤(06186)12月19日斥资3577.02万港元回购852.9万股） ...

中国飞鹤(06186)发布公告，于2025年12月19日斥资3577.02万港元回购852.9万股。 ...